Literature DB >> 21615805

The effect of the classical and medium chain triglyceride ketogenic diet on vitamin and mineral levels.

S S Christodoulides1, E G Neal, G Fitzsimmons, H M Chaffe, Y M Jeanes, H Aitkenhead, J H Cross.   

Abstract

BACKGROUND: The risk of nutritional deficiency in children on restrictive dietary treatments and a lack of ketogenic diet (KD)-specific UK supplements raises concerns about micronutrient status. Vitamin A, E, zinc, selenium and magnesium levels were therefore examined in children with intractable epilepsy treated with the KD.
METHODS: Plasma vitamins A and E, zinc, selenium and magnesium levels were measured at baseline and after 3, 6 and 12months on the classical (n=46) or medium chain triglyceride (MCT) (n=45) KD in children aged 2-16years, as part of a randomised trial, and pairwise comparisons with baseline were performed.
RESULTS: Data were available from 91 children. From baseline to 12months, mean plasma vitamin A decreased from 1.41μmol L(-1) to 1.13μmol L(-1) in the classical group (P<0.001) but increased from 1.52μmol L(-1) to 1.81μmol L(-1) in the MCT group (P<0.001). Mean plasma vitamin E increased from 22.7μmol L(-1) to 33.2μmol L(-1) in the classical group (P<0.001) and from 22.3 μmol L(-1) to 23.3μmol L(-1) in the MCT group (P<0.05). No significant change in plasma zinc was seen at 12months, although mean plasma selenium decreased from 0.95μmol L(-1) to 0.88μmol L(-1) in the group as a whole (P<0.05). Mean plasma magnesium decreased from 0.87mmol L(-1) to 0.83mmol L(-1) in the group as a whole (P<0.001); when subdivided by KD type, this was limited to the classical group.
CONCLUSIONS: Changes in plasma vitamins A and E and the decline in magnesium status after 12months of KD treatment suggest that micronutrient status may be suboptimal in this group and that available formulations for KD supplementation may need reviewing.
© 2011 The Authors. Journal of Human Nutrition and Dietetics © 2011 The British Dietetic Association Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21615805     DOI: 10.1111/j.1365-277X.2011.01172.x

Source DB:  PubMed          Journal:  J Hum Nutr Diet        ISSN: 0952-3871            Impact factor:   3.089


  13 in total

Review 1.  Safety and tolerability of the ketogenic diet used for the treatment of refractory childhood epilepsy: a systematic review of published prospective studies.

Authors:  Qian-Yun Cai; Zhong-Jie Zhou; Rong Luo; Jing Gan; Shi-Ping Li; De-Zhi Mu; Chao-Min Wan
Journal:  World J Pediatr       Date:  2017-07-12       Impact factor: 2.764

Review 2.  Dietary therapies for epilepsy: future research.

Authors:  Sudha K Kessler; Elizabeth G Neal; Carol S Camfield; Eric H Kossoff
Journal:  Epilepsy Behav       Date:  2011-03-26       Impact factor: 2.937

Review 3.  Ketogenic diets: new advances for metabolism-based therapies.

Authors:  Eric H Kossoff; Adam L Hartman
Journal:  Curr Opin Neurol       Date:  2012-04       Impact factor: 5.710

Review 4.  Medium chain triglycerides (MCT) formulas in paediatric and allergological practice.

Authors:  Ewa Łoś-Rycharska; Zuzanna Kieraszewicz; Mieczysława Czerwionka-Szaflarska
Journal:  Prz Gastroenterol       Date:  2016-07-20

5.  Optimal clinical management of children receiving dietary therapies for epilepsy: Updated recommendations of the International Ketogenic Diet Study Group.

Authors:  Eric H Kossoff; Beth A Zupec-Kania; Stéphane Auvin; Karen R Ballaban-Gil; A G Christina Bergqvist; Robyn Blackford; Jeffrey R Buchhalter; Roberto H Caraballo; J Helen Cross; Maria G Dahlin; Elizabeth J Donner; Orkide Guzel; Rana S Jehle; Joerg Klepper; Hoon-Chul Kang; Danielle A Lambrechts; Y M Christiana Liu; Janak K Nathan; Douglas R Nordli; Heidi H Pfeifer; Jong M Rho; Ingrid E Scheffer; Suvasini Sharma; Carl E Stafstrom; Elizabeth A Thiele; Zahava Turner; Maria M Vaccarezza; Elles J T M van der Louw; Pierangelo Veggiotti; James W Wheless; Elaine C Wirrell
Journal:  Epilepsia Open       Date:  2018-05-21

6.  An Experimental Ketogenic Diet for Alzheimer Disease Was Nutritionally Dense and Rich in Vegetables and Avocado.

Authors:  Matthew K Taylor; Russell H Swerdlow; Jeffrey M Burns; Debra K Sullivan
Journal:  Curr Dev Nutr       Date:  2019-02-20

7.  Safety and Effectiveness of the Prolonged Treatment of Children with a Ketogenic Diet.

Authors:  Jana Ruiz Herrero; Elvira Cañedo Villarroya; Juan José García Peñas; Beatriz García Alcolea; Begoña Gómez Fernández; Laura Andrea Puerta Macfarland; Consuelo Pedrón Giner
Journal:  Nutrients       Date:  2020-01-24       Impact factor: 5.717

8.  Differential ketogenic diet-induced shift in CSF lipid/carbohydrate metabolome of pediatric epilepsy patients with optimal vs. no anticonvulsant response: a pilot study.

Authors:  Susan A Masino; David N Ruskin; Natalie R Freedgood; Marie Lindefeldt; Maria Dahlin
Journal:  Nutr Metab (Lond)       Date:  2021-03-01       Impact factor: 4.169

9.  Biochemical assessment of patients following ketogenic diets for epilepsy: Current practice in the UK and Ireland.

Authors:  Natasha E Schoeler; Zoe Simpson; Victoria J Whiteley; Patty Nguyen; Rachel Meskell; Kathyrn Lightfoot; Kirsty J Martin-McGill; Simon Olpin; Fiona Ivison
Journal:  Epilepsia Open       Date:  2019-11-29

10.  Classic Ketogenic Diet and Modified Atkins Diet in SLC2A1 Positive and Negative Patients with Suspected GLUT1 Deficiency Syndrome: A Single Center Analysis of 18 Cases.

Authors:  Jana Ruiz Herrero; Elvira Cañedo Villarroya; Luis González Gutiérrez-Solana; Beatriz García Alcolea; Begoña Gómez Fernández; Laura Andrea Puerta Macfarland; Consuelo Pedrón-Giner
Journal:  Nutrients       Date:  2021-03-04       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.